Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection

Severe fever with thrombocytopenia syndrome (SFTS), an emerging life-threatening infectious disease caused by SFTS bunyavirus (SFTSV; genus Bandavirus, family Phenuiviridae, order Bunyavirales), has been a significant medical problem. Currently, there are no licensed vaccines or specific therapeutic agents available and the viral pathogenesis remains largely unclear. Developing appropriate animal models capable of recapitulating SFTSV infection in humans is crucial for both the study of the viral pathogenic processes and the development of treatment and prevention strategies. Here, we review the current progress in animal models for SFTSV infection by summarizing susceptibility of various potential animal models to SFTSV challenge and the clinical manifestations and histopathological changes in these models. Together with exemplification of studies on SFTSV molecular mechanisms, vaccine candidates, and antiviral drugs, in which animal infection models are utilized, the strengths and limitations of the existing SFTSV animal models and some important directions for future research are also discussed. Further exploration and optimization of SFTSV animal models and the corresponding experimental methods will be undoubtedly valuable for elucidating the viral infection and pathogenesis and evaluating vaccines and antiviral therapies.

[1]  L. Bao,et al.  The Ablation of Envelope Protein Glycosylation Enhances the Neurovirulence of ZIKV and Cell Apoptosis in Newborn Mice , 2021, Journal of immunology research.

[2]  T. Nabeshima,et al.  Severe Fever with Thrombocytopenia Syndrome in Cats and Its Prevalence among Veterinarian Staff Members in Nagasaki, Japan , 2021, Viruses.

[3]  Zhiwei Wu,et al.  Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome , 2021, PLoS pathogens.

[4]  XianWei Wang,et al.  A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice. , 2021, Veterinary microbiology.

[5]  Jian-wei Liu,et al.  SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome Activation , 2021, Frontiers in Immunology.

[6]  M. Shimojima,et al.  Pathological Characteristics of a Patient with Severe Fever with Thrombocytopenia Syndrome (SFTS) Infected with SFTS Virus through a Sick Cat’s Bite , 2021, Viruses.

[7]  Y. Kirino,et al.  Direct Transmission of Severe Fever with Thrombocytopenia Syndrome Virus from Domestic Cat to Veterinary Personnel , 2020, Emerging infectious diseases.

[8]  F. Dèng,et al.  Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly , 2020, PLoS pathogens.

[9]  Tadaki Suzuki,et al.  Virus-infected peripheral blood plasmablasts in a patient with severe fever with thrombocytopenia syndrome , 2020, International Journal of Hematology.

[10]  H. Feldmann,et al.  Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus , 2020, bioRxiv.

[11]  S. Eo,et al.  Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling , 2020, Laboratory animal research.

[12]  Steven B. Bradfute,et al.  2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. , 2020, Archives of virology.

[13]  J. Kuhn,et al.  A Model for the Production of Regulatory Grade Viral Hemorrhagic Fever Exposure Stocks: From Field Surveillance to Advanced Characterization of SFTSV , 2020, Viruses.

[14]  M. Shimojima,et al.  A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome , 2020, bioRxiv.

[15]  Bian-Li Xu,et al.  Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes , 2020, BMC Infectious Diseases.

[16]  Nam-Hyuk Cho,et al.  Genotypic Heterogeneity of Orientia tsutsugamushi in Scrub Typhus Patients and Thrombocytopenia Syndrome Co-infection, Myanmar , 2020, Emerging infectious diseases.

[17]  Yan Li,et al.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy , 2020, Science.

[18]  Zhiwei Wu,et al.  A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo. , 2020, JCI insight.

[19]  H. Wen,et al.  Severe fever with thrombocytopenia syndrome virus infection during pregnancy in C57/BL6 mice causes fetal damage , 2020, PLoS neglected tropical diseases.

[20]  Hongbin He,et al.  Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice , 2020, Frontiers in Microbiology.

[21]  F. Dèng,et al.  A RIG-I–like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination , 2020, The Journal of Biological Chemistry.

[22]  M. Hu,et al.  Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation , 2020, Nature Microbiology.

[23]  Eun-Ha Kim,et al.  Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.

[24]  F. Dèng,et al.  Guertu virus NSs protein disrupts host defense by blocking antiviral interferon induction and action. , 2020, ACS infectious diseases.

[25]  S. Günther,et al.  Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein , 2020, bioRxiv.

[26]  M. Saijo,et al.  Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection , 2020, Frontiers in Microbiology.

[27]  M. Shimojima,et al.  Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections. , 2020, The Journal of clinical investigation.

[28]  H. Shimoda,et al.  The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan , 2020, Emerging microbes & infections.

[29]  Jungsang Ryou,et al.  Genetic and Pathogenic-Diversity of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) in South Korea. , 2019, JCI insight.

[30]  Jae U. Jung,et al.  Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model , 2019, Proceedings of the National Academy of Sciences.

[31]  Y. Jeon,et al.  Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice , 2019, bioRxiv.

[32]  T. Steiner,et al.  Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice , 2019, Pathogens.

[33]  H. Ebihara,et al.  Immune Modulation and Immune-Mediated Pathogenesis of Emerging Tickborne Banyangviruses , 2019, Vaccines.

[34]  Geng-fu Xiao,et al.  Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality , 2019, Cell Research.

[35]  Jae U. Jung,et al.  Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets , 2019, Nature Communications.

[36]  M. Shimojima,et al.  Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats , 2019, Scientific Reports.

[37]  Su-Jin Park,et al.  Shedding and Transmission Modes of Severe Fever With Thrombocytopenia Syndrome Phlebovirus in a Ferret Model , 2019, Open forum infectious diseases.

[38]  Zheng Xing,et al.  Susceptibility of spotted doves (Streptopelia chinensis) to experimental infection with the severe fever with thrombocytopenia syndrome phlebovirus , 2019, PLoS neglected tropical diseases.

[39]  Todd M. Allen,et al.  Humanized immune system mouse models: progress, challenges and opportunities , 2019, Nature Immunology.

[40]  Zhìhóng Hú,et al.  Interferon-γ-Directed Inhibition of a Novel High-Pathogenic Phlebovirus and Viral Antagonism of the Antiviral Signaling by Targeting STAT1 , 2019, Front. Immunol..

[41]  W. Choi,et al.  Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[42]  Xuan Chuong Tran,et al.  Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam , 2019, Emerging infectious diseases.

[43]  Zhìhóng Hú,et al.  Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1 , 2019, The Journal of Biological Chemistry.

[44]  Saori Sakabe,et al.  Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs , 2019, Journal of Virology.

[45]  J. Chae,et al.  Severe Fever with Thrombocytopenia Syndrome Virus in Dogs, South Korea , 2019, Emerging infectious diseases.

[46]  K. Chandran,et al.  Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus , 2019, npj Vaccines.

[47]  P. Tsichlis,et al.  Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis , 2019, Nature Microbiology.

[48]  Su-Jin Park,et al.  Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis , 2018, Nature Microbiology.

[49]  D. Smee,et al.  2′‐Fluoro‐2′‐deoxycytidine is a broad‐spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models , 2018, Antiviral research.

[50]  Jinhe Kim,et al.  An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus , 2018, bioRxiv.

[51]  W. Cao,et al.  Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study. , 2018, The Lancet. Infectious diseases.

[52]  M. Saijo Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[53]  M. Shimojima,et al.  Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration , 2018, bioRxiv.

[54]  P. Thomas,et al.  Moving Forward: Recent Developments for the Ferret Biomedical Research Model , 2018, mBio.

[55]  Shibo Li,et al.  Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case , 2018, Virology Journal.

[56]  G. Gao,et al.  Bunyavirales ribonucleoproteins: the viral replication and transcription machinery , 2018, Critical reviews in microbiology.

[57]  M. Shimojima,et al.  A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[58]  Yeu‐Chun Kim,et al.  Nano-patterning of a stainless steel microneedle surface to improve the dip-coating efficiency of a DNA vaccine and its immune response. , 2017, Colloids and surfaces. B, Biointerfaces.

[59]  Zhìhóng Hú,et al.  Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase–IRF3 transcription factor interaction and signaling required for interferon induction , 2017, The Journal of Biological Chemistry.

[60]  S. Ceman,et al.  Mov10 suppresses retroelements and regulates neuronal development and function in the developing brain , 2017, BMC Biology.

[61]  K. Shiogama,et al.  Hemophagocytic Lymphohistiocytosis in a Fatal Case of Severe Fever with Thrombocytopenia Syndrome , 2017, Internal medicine.

[62]  D. Greiner,et al.  Humanized Mouse Models of Clinical Disease. , 2017, Annual review of pathology.

[63]  H. Ebihara,et al.  Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection , 2017, Front. Microbiol..

[64]  B. Gowen,et al.  Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir , 2016, Journal of Virology.

[65]  Laurence Zitvogel,et al.  Mouse models in oncoimmunology , 2016, Nature Reviews Cancer.

[66]  Haruo Watanabe,et al.  Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus , 2016, mSphere.

[67]  Zheng Xing,et al.  Host Responses and Regulation by NFκB Signaling in the Liver and Liver Epithelial Cells Infected with A Novel Tick-borne Bunyavirus , 2015, Scientific Reports.

[68]  De-xin Li,et al.  [Infection of the Severe Fever with Thrombocytopenia Syndrome Virus in Balb/C Mice and Hamsters]. , 2015, Bing du xue bao = Chinese journal of virology.

[69]  Guillermo Posadas-Herrera,et al.  Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection , 2015, Virology.

[70]  De-xin Li,et al.  SFTS virus infection in nonhuman primates. , 2015, The Journal of infectious diseases.

[71]  C. Rice,et al.  Interferons and viruses: an evolutionary arms race of molecular interactions. , 2015, Trends in immunology.

[72]  W. Cao,et al.  Immunization with recombinant SFTSV/NSs protein does not promote virus clearance in SFTSV-infected C57BL/6J mice. , 2015, Viral immunology.

[73]  Xue-Jie Yu,et al.  Severe fever with thrombocytopenia syndrome and its pathogen SFTSV. , 2015, Microbes and infection.

[74]  W. Cao,et al.  Disruption of Type I Interferon Signaling by the Nonstructural Protein of Severe Fever with Thrombocytopenia Syndrome Virus via the Hijacking of STAT2 and STAT1 into Inclusion Bodies , 2015, Journal of Virology.

[75]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[76]  M. Saijo,et al.  Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: A pathognomonic histological feature and unique complication of SFTS , 2014, Pathology international.

[77]  M. Pichichero,et al.  Immune responses in neonates , 2014, Expert review of clinical immunology.

[78]  B. He,et al.  Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. , 2014, The Lancet. Infectious diseases.

[79]  M. Han,et al.  Severe Fever with Thrombocytopenia Syndrome Virus in Ticks Collected from Humans, South Korea, 2013 , 2014, Emerging infectious diseases.

[80]  W. Liu,et al.  Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform , 2014, Journal of molecular cell biology.

[81]  A. García-Sastre,et al.  Hijacking of RIG-I Signaling Proteins into Virus-Induced Cytoplasmic Structures Correlates with the Inhibition of Type I Interferon Responses , 2014, Journal of Virology.

[82]  Zheng Xing,et al.  Evasion of Antiviral Immunity through Sequestering of TBK1/IKKε/IRF3 into Viral Inclusion Bodies , 2013, Journal of Virology.

[83]  H. Lv,et al.  Systematic review of severe fever with thrombocytopenia syndrome:virology, epidemiology, and clinical characteristics , 2013, Reviews in medical virology.

[84]  R. Tesh,et al.  The Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus Infection in Alpha/Beta Interferon Knockout Mice: Insights into the Pathologic Mechanisms of a New Viral Hemorrhagic Fever , 2013, Journal of Virology.

[85]  M. Shimojima,et al.  The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan , 2013, The Journal of infectious diseases.

[86]  Hao Yu,et al.  An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV , 2013, Science China Life Sciences.

[87]  Z. Bi,et al.  Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. , 2012, The Journal of infectious diseases.

[88]  A. MacNeil,et al.  A new phlebovirus associated with severe febrile illness in Missouri. , 2012, The New England journal of medicine.

[89]  Shiwen Wang,et al.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model , 2012, Proceedings of the National Academy of Sciences.

[90]  Ming-hui Li,et al.  Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. , 2012, The Journal of general virology.

[91]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[92]  Gabriele Neumann,et al.  Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets , 2012, Nature.

[93]  J. Klena,et al.  A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  Yuan Zhang,et al.  Metagenomic Analysis of Fever, Thrombocytopenia and Leukopenia Syndrome (FTLS) in Henan Province, China: Discovery of a New Bunyavirus , 2011, PLoS pathogens.

[95]  Weizhong Yang,et al.  Fever with thrombocytopenia associated with a novel bunyavirus in China. , 2011, The New England journal of medicine.

[96]  Ming-hui Li,et al.  Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. , 2011, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[97]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[98]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[99]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[100]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[101]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[102]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[103]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[104]  S. Adunyah,et al.  Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. , 1999, Biochemical and biophysical research communications.

[105]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[106]  P. Heinrich,et al.  The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family , 1994, Molecular and cellular biology.

[107]  M. Shimojima,et al.  RLRs and TLRs Signaling Pathways Cause Aberrant Production of Inflammatory 1 Cytokines / Chemokines in an SFTSV Infection Mouse Model 2 3 , 2018 .

[108]  Tadaki Suzuki,et al.  Fatal Severe Fever with Thrombocytopenia Syndrome: An Autopsy Case Report. , 2016, Internal medicine.

[109]  M. Han,et al.  Severe Fever with Thrombocytopenia Syndrome Virus , 2014 .

[110]  K. Bradford,et al.  Development and Maturation , 2013 .

[111]  D. Chaplin,et al.  Development and maturation of secondary lymphoid tissues. , 1999, Annual review of immunology.

[112]  M. Bray,et al.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. , 1998, The Journal of infectious diseases.

[113]  A. Davies,et al.  Immune Responses , 1971, Nature.

[114]  George F. Dowdeswell,et al.  On rabies , 1888, Proceedings of the Royal Society of London.